Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-06-22

FDA Approved: ERLOTINIB — Original Application (Aurobindo Pharma Limited)

View source ↗

Summary

The FDA approved Aurobindo Pharma Limited's original application for a generic erlotinib product. Erlotinib is used to treat certain cancers, notably non-small …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ERLOTINIB (Erlotinib)

Snippet

ORIG AP for ERLOTINIB (ERLOTINIB)